Bepotastine besilate

苯磺贝他斯汀

Report date: 2026/03/20 20:03:07
NME

Base Information

Drug NameBepotastine besilate
Drug Alias Name贝托斯汀BepotastinaBepotastinum苯磺酸贝托司汀苯磺酸贝他斯汀 +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsUrticariaPruritusPrurigo +[8] 
Global Approved IndicationsUrticariaPrurigoConjunctivitis, Allergic +[6] 
Approved Indications in ChinaUrticariaPrurigoRhinitis, Allergic
Original Approved Country/TerritoryJapan
Original Approved Date2000/07/03
Country/TerritoryUnited StatesMexicoSouth Korea +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesUbe Industries Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIsta PharmaceuticalsBausch & Lomb IncorporatedMitsubishi Tanabe Pharma +[4] 
Inactive CompaniesHanmi Pharmaceutical Co LtdLaboratorios Sophia Sa De CvMitsubishi Tanabe Pharma Corp +[4] 
Active IndicationsUrticariaPrurigoConjunctivitis, Allergic +[6] 
Inactive IndicationsPruritusRhinitis, Allergic, Seasonal

Other Information

ATC CodeS01
Related LinksWikipediaDrugBankKEGG